CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.83
+0.58 (7.03%)
At close: Aug 1, 2025, 4:00 PM
8.64
-0.19 (-2.15%)
After-hours: Aug 1, 2025, 7:56 PM EDT
Accolade Stock Forecast
Stock Price Forecast
The 5 analysts that cover Accolade stock have a consensus rating of "Strong Buy" and an average price target of $17.4, which forecasts a 97.06% increase in the stock price over the next year. The lowest target is $10 and the highest is $27.
Price Target: $17.40 (+97.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Accolade stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 6 | 6 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $21 → $27 | Strong Buy | Maintains | $21 → $27 | +205.78% | Jul 29, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +13.25% | Jul 28, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +13.25% | Jul 25, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +13.25% | Jun 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +13.25% | May 13, 2025 |
Financial Forecast
Revenue This Year
6.42M
from 9.74M
Decreased by -34.04%
Revenue Next Year
n/a
from 6.42M
EPS This Year
-2.06
from -2.02
EPS Next Year
-1.81
from -2.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.3M | n/a | n/a | ||
| Avg | 6.4M | n/a | n/a | ||
| Low | 2.9M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.3% | - | - | ||
| Avg | -34.0% | - | - | ||
| Low | -69.8% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.34 | -0.63 | -0.36 | ||
| Avg | -2.06 | -1.81 | -1.81 | ||
| Low | -2.52 | -2.76 | -3.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.